Biotechnology News & Press Release Distribution

Biotechnology

APAC
Global

Ascentage Pharma Announces IND Clearance by the US FDA for First-in-Human Study of Novel EED Inhibitor APG-5918

SUZHOU, China and ROCKVILLE, Md., June 29, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that its novel inhibitor of the embryonic ectoderm...

2022-06-30 10:41 1533

Catalent Expands Primary Packaging Capabilities at its Clinical Supply Facility in Shiga, Japan

SHANGHAI, June 30, 2022 /PRNewswire/ -- Catalent, the global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that it has expanded its primary packaging capabi...

2022-06-30 08:00 2558

Catalent Expands Primary Packaging Capabilities at its Clinical Supply Facility in Shiga, Japan

Eurofins DiscoverX Celebrates Shanghai Office Opening

SHANGHAI, June 30, 2022 /PRNewswire/ -- Eurofins DiscoverX (Eurofins DiscoverX Products LLC), a global industry leader of products for small and large molecule drug discovery and QC lot release, today announced the official opening of its newChina biotechnology office in Shanghai.

2022-06-30 01:00 2634

Eurofins DiscoverX Celebrates Shanghai Office Opening

Sequential awarded prestigious Innovate UK SMART Grant to propel understanding of skin microbiome forward

LONDON and NEW YORK and SINGAPORE, June 29, 2022 /PRNewswire/ -- Sequential Skin Ltd , a leading skin genomics start-up, has been awarded anInnovate UK SMART Grant to fund a project on advancing current understanding of ...

2022-06-29 08:32 1851

Sequential awarded prestigious Innovate UK SMART Grant to propel understanding of skin microbiome forward

Innovent Announces Phase 1b Study Results of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes Published in Nature Communications

SAN FRANCISCO and SUZHOU, China, June 29, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...

2022-06-29 08:00 2236

Palleon Pharmaceuticals and Henlius Enter into Strategic Collaboration to Develop Bifunctional Sialidase Therapies

* Palleon and Henlius to co-develop Bifunctional HER2-Sialidase and a second bifunctional sialidase to be jointly designed - * Henlius received exclusive license for two products in China (including Hong Kong, Macau, and Taiwan); Palleon retains all other global rights - * Palleon receives u...

2022-06-28 21:50 2567

iNtRON to Seek a New Clinical Partner for SAL200 Endolysin

* TONABACASE, the first registered INN by WHO for Endolysin * First-in-Class Endolysin-based Drug against Superbugs * US FDA Phase 2 IND Approval for TONABACASE, SAL200 * Roivant has returned the rights for the asset just before the first patient injection BOSTON and SEOUL, South Korea, Jun...

2022-06-28 21:00 1557

New hope for IVF patients as global study published in Human Reproduction shows AI can effectively assess genetic integrity of embryos

SAN FRANCISCO, June 28, 2022 /PRNewswire/ -- Human Reproduction journal has published the ground-breaking results of an international clinical study, where a novel AI algorithm called Life Whisperer Genetics was developed by AI healthcare company Presegen to assess the genetic integrity of embryo...

2022-06-28 19:07 1345

IFN Neurologic and MetaCell Partner to Launch the IFN Neurologic Affiliate Program

CAMBRIDGE, Mass., and PERTH, Australia, June 28, 2022 /PRNewswire/ -- Summary The Institute of Functional Neuroscience, a world leading treatment and rehabilitation centre utilising the latest technologies in neuroplasticity research, and MetaCell, an innovative life science software company spe...

2022-06-28 09:05 2049

IFN Neurologic and MetaCell Partner to Launch the IFN Neurologic Affiliate Program

Transcenta was Selected to Present the Preclinical Data of TST004 at the 2022 ISN Frontiers Meetings of Complement Related Kidney Diseases

SUZHOU, China, June 28, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that it was selected ...

2022-06-28 08:00 1811

BGI Group Continues To Lead In Life Sciences 22 Years After The Human Genome Project

SHENZHEN, China, June 27, 2022 /PRNewswire/ -- BGI Group continues to lead in life sciences, making breakthroughs from single cell technology to spatiotemporal genomics, 22 years after participating in the Human Genome Project (HGP). BGI was formed to be a part of the HGP, contributing to the se...

2022-06-27 16:20 1849

Abcam: Appointment of Vice President of Investor Relations

CAMBRIDGE, England, June 27, 2022 /PRNewswire/ -- Abcam plc ("Abcam," "Company," "Group") (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces the appointment ofTommy Thomas as Vice President of Investor Relations...

2022-06-27 14:00 2788

Antengene Announces Clinical Trial Collaboration with BeiGene to Evaluate Selinexor in Combination with Tislelizumab in T and NK-Cell Lymphoma

- Selinexor is an oral small molecule XPO1 inhibitor; tislelizumab is an anti-PD-1 checkpoint inhibitor SHANGHAI and HONG KONG, June 27, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedi...

2022-06-27 08:30 2340

Congratulations to Dragon Boat Biopharmaceutical from Sanyou Biopharmaceuticals on the NMPA acceptance of the CLDN 18.2/CD47 bsAb clinical trial application

SHANGHAI, June 25, 2022 /PRNewswire/ -- On June 15, 2022, Dragon Boat announced that its IND application of the innovative anti-CLDN 18.2/CD47 bi-specific antibody (bsAb) injection (R&D code: BC007) was officially accepted by National Medical Products Administration (NMPA) under the acceptance nu...

2022-06-26 08:00 3506

Sanyou Biopharmaceuticals forged strategic partnership with Dragon Sail Pharmaceutical to upgrade integrated innovative antibody drug R&D

SHANGHAI, June 24, 2022 /PRNewswire/ -- Sanyou Biopharmaceuticals, a biological high-tech enterprise focusing on R&D and services of innovative antibody drugs, and Dragon Sail Pharmaceutical, aCDMO and CMO enterprise dedicated to providing world-leading high-end biological drug manufacture servic...

2022-06-25 08:00 4877

Daewoong Pharmaceutical begins multinational phase 2 clinical trial for DWN12088, a new drug for idiopathic pulmonary fibrosis

- U.S. Food and Drug Administration (FDA) approved the IND for the phase 2 clinical trial for patients with idiopathic pulmonary fibrosis - Daewoong Pharmaceutical to start a multinational phase 2 clinical trial for DWN12088 in September SEOUL, South Korea, June 24, 2022 /PRNewswire/ -- Daewoong...

2022-06-24 21:00 3341

Novavax COVID-19 Vaccine Nuvaxovid™ Recommended for Expanded Conditional Marketing Authorization in the European Union by CHMP for Adolescents Aged 12 Through 17

* Upon authorization, Nuvaxovid™ would be the first protein-based option for adolescents aged 12 through 17 inEurope * Nuvaxovid™ demonstrated 80% efficacy and was generally well-tolerated in adolescents GAITHERSBURG, Md., June 24, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechn...

2022-06-24 03:24 3140

Use of BioMAP Platform to Assess Nutraceuticals Published in BioMed Central

ST. CHARLES, Mo., June 24, 2022 /PRNewswire/ -- Eurofins Discovery, the leading brand with over 35 years of success providing a complete solution of products and services for drug discovery, announces a client publication advancing cognitive health research through use of the company's BioMAP...

2022-06-24 01:00 2497

MGI Wins Company Innovation of the Year at 2022 Globee® Awards for Advanced COVID-19 Response Efforts

SHENZHEN, China, June 24, 2022 /PRNewswire/ -- MGI, a company committed to being a world-leading life science innovator, has been awarded a Silver Globee® in the 14th Annual 2022 Golden Bridge Business and Innovation Awards® for its innovative COVID-19 pandemic control and response efforts worldw...

2022-06-24 00:17 2859

Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial in Italy

MELBOURNE, Australia and SAN FRANCISCO, June 23, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that the Italian Medicin...

2022-06-23 23:00 2194

1 ... 127 128 129130131 132 133 ... 280